VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹112 Cr | ₹80 Cr | ₹77 Cr | ₹39 Cr | ₹32 Cr |
What is the latest Sundry Debtors ratio of VENUS REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹112 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹32 Cr |
How is Sundry Debtors of VENUS REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹112 Cr | 39.40 | |
| Mar2024 | ₹80 Cr | 5.01 | |
| Mar2023 | ₹77 Cr | 98.60 | |
| Mar2022 | ₹39 Cr | 20.47 | |
| Mar2021 | ₹32 Cr | - | |
Compare Sundry Debtors of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹998.6 Cr | 2.7% | 68.6% | 137.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 2.7% |
68.6% |
137.6% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses